REACTION OF THE CIRCULATING REGULATORY T CELLS AFTER CHEMORADIATION THERAPY OF HODGKIN LYMPHOMA

REACTION OF THE CIRCULATING REGULATORY T CELLS AFTER CHEMORADIATION THERAPY OF HODGKIN LYMPHOMA

Objective: Purpose of the research is to determine the reaction of regulatory T cells after chemoradiation therapy of Hodgkin lymphoma. Methodology: 29 samples of peripheral blood of patients with Hodgkin lymphoma (before treatment – 10; after chemotherapy – 9; after consolidation radiotherapy – 10)...

Full description

Bibliographic Details
Main Authors:	Tatiana Mushkarina, Evgenija Kuzmina, Tatiana Bogatyreva, Ludmila Grivtsova
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137923002365

Similar Items

Endoscopic evaluation of small bowel lesions in Hodgkin's lymphoma patients during chemoradiation therapy
by: D. A. Khomov, et al.
Published: (2022-11-01)

Clinical possibilities of flow cytometry in hodgkin’s lymphoma
by: F. M. Abbasbeyli, et al.
Published: (2023-09-01)

A STRATEGY FOR DIRECT DELIVERY OF ANTIGENIC CONSTRUCTS TO DENDRITIC CELL RECEPTORS
by: Anzhelika Melnikova, et al.
Published: (2024-05-01)

Identification of Reed-Berezovsky-Sternberg cells in lymphatic nodes in classic Hodgkin's lymphoma by flow cytometry: a clinical case series
by: Firuza М. Abbasbeyli, et al.
Published: (2023-06-01)

Bone marrow composition features and possibilities of tumor involvement diagnosing in patients with classic Hodgkin’s lymphoma
by: F. M. Abbasbeyli, et al.
Published: (2023-09-01)

Immunological features of the bone marrow microenvironment and assessment of bone marrow lesions in patients with classical Hodgkin lymphoma
by: A. A. Melnikova, et al.
Published: (2024-09-01)

Non-Hodgkin's lymphoma after immunosuppressive therapy.
by: Kinlen, L
Published: (2000)

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
by: Valentina Giudice, et al.
Published: (2022-04-01)

Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma
by: David M. Kurtz
Published: (2021-01-01)

Secondary malignancies after therapy of indolent non-Hodgkin’s lymphoma
by: Jonathan W. Friedberg
Published: (2008-03-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
by: Mikalai Katsin, et al.
Published: (2023-12-01)

Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01)

New approaches for combined therapy of Hodgkin's lymphoma
by: P. V. Dacenko, et al.
Published: (2022-11-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

Hodgkin Lymphoma Development After the Diagnosis of Idiopathic
by: Oktay Bilgir, et al.
Published: (2014-08-01)

Hodgkin’s Lymphoma after Initiation of Antiretroviral Therapy in a Patient from India
by: Vinay Kumar Konan, et al.
Published: (2024-09-01)

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
by: Alvaro, T, et al.
Published: (2005)

Oncologic outcomes of squamous cell carcinoma of the anal canal after chemoradiation therapy
by: Dae Ro Lim, et al.
Published: (2016-06-01)

Composite Lymphoma: Hodgkin and Non-Hodgkin Lymphoma A Case Report
by: Noorwati Soetandyo, et al.
Published: (2018-09-01)

ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
by: Eldad J Dann
Published: (2014-09-01)

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma
by: Reid W. Merryman, et al.
Published: (2017-12-01)

The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy
by: David Pereg, et al.
Published: (2007-09-01)

Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01)

Macrophages in Hodgkin's lymphoma.
by: Pazianas, M
Published: (2010)

EBV IN HODGKIN LYMPHOMA
by: Giuseppina Massini, et al.
Published: (2009-11-01)

EBV IN HODGKIN LYMPHOMA
by: Stefan Hohaus, et al.
Published: (2009-11-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

Pathobiology of Hodgkin Lymphoma
by: Pier Paolo Piccaluga, et al.
Published: (2011-01-01)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
by: Ahmet Dogan
Published: (2022-10-01)

T008 (0050) GENOTYPING CIRCULATING TUMOR DNA OF PEDIATRIC HODGKIN LYMPHOMA PATIENTS TO DETERMINE PATHOGENIC MECHANISMS AND MONITOR THERAPY
Published: (2018-10-01)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
by: Paola Parente, et al.
Published: (2020-11-01)

P1283: CIRCULATING IMMUNE CELLS IN CLASSICAL HODGKIN LYMPHOMA IN RELATION TO TUMOR BURDEN AND TREATMENT
by: T. A. Mulder, et al.
Published: (2022-06-01)

Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin’s lymphoma and T-cell non-Hodgkin’s lymphoma
by: Maria Kleppe, et al.
Published: (2011-11-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
by: Tinkl, D, et al.
Published: (2009)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
by: Krischan Braitsch, et al.
Published: (2018-10-01)

THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA
by: Dennis A Eichenauer, et al.
Published: (2011-10-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Raffaella Marcheselli, et al.
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Alessia Bari, et al.
Published: (2011-12-01)

The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
by: Yuliya Andreevna Veryaskina, et al.
Published: (2020-10-01)